158 related articles for article (PubMed ID: 20736131)
21. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
[TBL] [Abstract][Full Text] [Related]
22. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
23. [Anti-Müllerian hormone, an endocrine predictor of the response to ovarian stimulation in the bovine species].
Monniaux D; Rico C; Larroque H; Dalbiès-Tran R; Médigue C; Clément F; Fabre S
Gynecol Obstet Fertil; 2010; 38(7-8):465-70. PubMed ID: 20580592
[TBL] [Abstract][Full Text] [Related]
24. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
25. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Apr; 91(4 Suppl):1553-5. PubMed ID: 19217095
[TBL] [Abstract][Full Text] [Related]
26. Controlled ovarian hyperstimulation. Relationship of early serum E2 levels to the ultimate response of oocyte donors.
Kavic S; Cohen MA; Sauer MV; Lindheim SR
J Reprod Med; 2001 Jul; 46(7):637-40. PubMed ID: 11499183
[TBL] [Abstract][Full Text] [Related]
27. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Hum Reprod; 2010 Oct; 25(10):2597-604. PubMed ID: 20729237
[TBL] [Abstract][Full Text] [Related]
28. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
Nelson SM; Yates RW; Lyall H; Jamieson M; Traynor I; Gaudoin M; Mitchell P; Ambrose P; Fleming R
Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673
[TBL] [Abstract][Full Text] [Related]
29. Serum inhibin B during controlled ovarian hyperstimulation: an additional criterion for deciding whether to proceed with egg retrieval.
Decanter C; Pigny P; Lefebvre C; Thomas P; Leroy M; Dewailly D
Fertil Steril; 2009 Jun; 91(6):2419-25. PubMed ID: 18555227
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination.
Li HW; Yeung WS; Lau EY; Ho PC; Ng EH
Fertil Steril; 2010 Nov; 94(6):2177-81. PubMed ID: 20171627
[TBL] [Abstract][Full Text] [Related]
31. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
32. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?
Martínez F; Clua E; Carreras O; Tur R; Rodríguez I; Barri PN
Gynecol Endocrinol; 2013 Aug; 29(8):754-7. PubMed ID: 23758138
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
34. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
35. Negligible serum anti-müllerian hormone: pregnancy and birth after a 1-month course of an oral contraceptive, ovarian hyperstimulation, and intracytoplasmic sperm injection.
Tocci A; Ferrero S; Iacobelli M; Greco E
Fertil Steril; 2009 Jul; 92(1):395.e9-395.e12. PubMed ID: 19410249
[TBL] [Abstract][Full Text] [Related]
36. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
37. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
[TBL] [Abstract][Full Text] [Related]
38. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.
Nelson SM; Yates RW; Fleming R
Hum Reprod; 2007 Sep; 22(9):2414-21. PubMed ID: 17636277
[TBL] [Abstract][Full Text] [Related]
39. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation.
Borges E; Braga DPAF; Setti A; Figueira RC; Iaconelli A
JBRA Assist Reprod; 2017 Sep; 21(3):176-182. PubMed ID: 28837024
[TBL] [Abstract][Full Text] [Related]
40. Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation.
Delesalle AS; Robin G; Thomas-Desrousseaux P; Dewailly D; Catteau-Jonard S
Reprod Biol Endocrinol; 2016 Jan; 14():4. PubMed ID: 26787450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
